Advisory Services Network’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-27,000
| Closed | -$24.7K | – | 1476 |
|
|
2023
Q2 | $24.7K | Buy |
+27,000
| New | +$24.7K | ﹤0.01% | 1421 |
|
|
2022
Q2 | – | Sell |
-39,315
| Closed | -$28K | – | 1375 |
|
|
2022
Q1 | $28K | Hold |
39,315
| – | – | ﹤0.01% | 1430 |
|
|
2021
Q4 | $89K | Hold |
39,315
| – | – | ﹤0.01% | 1364 |
|
|
2021
Q3 | $113K | Hold |
39,315
| – | – | ﹤0.01% | 1329 |
|
|
2021
Q2 | $149K | Hold |
39,315
| – | – | ﹤0.01% | 1401 |
|
|
2021
Q1 | $133K | Hold |
39,315
| – | – | ﹤0.01% | 1227 |
|
|
2020
Q4 | $110K | Sell |
39,315
-500
| -1% | -$1.4K | ﹤0.01% | 1289 |
|
|
2020
Q3 | $100K | Buy |
39,815
+29,072
| +271% | +$73K | ﹤0.01% | 1260 |
|
|
2020
Q2 | $146K | Hold |
10,743
| – | – | 0.01% | 975 |
|
|
2020
Q1 | $81K | Buy |
10,743
+6,439
| +150% | +$48.5K | 0.01% | 1163 |
|
|
2019
Q4 | $27K | Buy |
+4,304
| New | +$27K | ﹤0.01% | 1849 |
|